Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

_____________________

(Mark One)

x       QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: September 30, 2017March 31, 2021

 

o       TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission File Number: 000-17363

_____________________

 

LIFEWAY FOODS, INC.

(Exact Name of Registrant as Specified in its Charter)

_____________________

 

Illinois36-3442829

(State or Other Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer

Identification No.)

 

6431 West Oakton, Morton Grove, IL 60053

(Address of Principal Executive Offices, Zip Code)

 

(847) 967-1010

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 Title of each class Trading Symbol(s) Name of each exchange on which registered
 Common Stock, no par value LWAY Nasdaq Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yesx Noo

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x Noo

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one)

 

 Large accelerated filer  oAccelerated filer  o
 Non-accelerated filer   oxSmaller reporting company  x
 Emerging growth company  o 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  o No x

 

AsNumber of November 3, 2017, 16,024,264 shares of the registrant’s common stock,Common Stock, no par value, were outstanding.outstanding as of May 3, 2021: 15,631,314  

 

   

 

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION 
Item 1.Financial Statements.Statements.3
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations.1517
Item 3.Quantitative and Qualitative Disclosures About Market Risk.1922
Item 4.Controls and Procedures.1922
  
PART II – OTHER INFORMATION 
Item 1.Legal Proceedings.Proceedings.2123
Item 1 A.1A.Risk Factors.2123
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds.2123
Item 3.Defaults Upon Senior Securities.2123
Item 4.Mine Safety Disclosure.2123
Item 5.Other Information.2123
Item 6.Exhibits.2124
 Signatures.22
Index of Exhibits.2325

 

 

 

 

 

 

 

 

 

 

 

 

 

 2 

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS.

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

September 30, 2017March 31, 2021 and December 31, 20162020

(In thousands)

  

September 30,

2017

(Unaudited)

  

December 31,

2016

 
Current assets        
Cash and cash equivalents $7,264  $8,812 
Accounts receivable, net of allowance for doubtful accounts and discounts & allowances of $1,160 and $1,600 at September 30, 2017 and December 31, 2016 respectively  10,408   9,594 
Inventories, net  8,050   8,042 
Prepaid expenses and other current assets  1,016   785 
Refundable income taxes  771   309 
Total current assets  27,509   27,542 
         
Property, plant and equipment, net  23,888   21,832 
         
Intangible assets        
Goodwill & indefinite-lived intangibles  14,068   14,068 
Other intangible assets, net  1,143   1,647 
Total intangible assets  15,211   15,715 
         
Other assets  150   125 
Total assets $66,758  $65,214 
         
Current liabilities        
Current maturities of notes payable $3,292  $840 
Accounts payable  7,104   5,718 
Accrued expenses  2,866   2,169 
Accrued income taxes  74   654 
Total current liabilities  13,336   9,381 
         
Notes payable  3,197   6,279 
Deferred income taxes, net  1,192   1,192 
Other long-term liabilities  406    
Total liabilities  18,131   16,852 
         
Stockholders' equity        
Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 16,037 and 16,154 outstanding at September 30, 2017 and December 31, 2016, respectively  6,509   6,509 
Paid-in capital  2,247   2,198 
Treasury stock, at cost  (11,527)  (10,340)
Retained earnings  51,398   49,995 
Total stockholders' equity  48,627   48,362 
         
Total liabilities and stockholders' equity $66,758  $65,214 

  

March 31,

2021

(Unaudited)

  

December 31,

2020

 
Current assets        
Cash and cash equivalents $8,618  $7,926 
Accounts receivable, net of allowance for doubtful accounts and discounts & allowances of $1,100 and $1,350 at March 31, 2021 and December 31, 2020 respectively  9,961   8,002 
Inventories, net  6,736   6,930 
Prepaid expenses and other current assets  1,110   1,163 
Refundable income taxes  46   31 
Total current assets  26,471   24,052 
         
Property, plant and equipment, net  20,744   21,048 
Operating lease right-of-use asset  317   345 
         
Intangible assets        
Goodwill and indefinite-lived intangibles  12,824   12,824 
Other intangible assets, net      
Total intangible assets  12,824   12,824 
         
Other assets  1,800   1,800 
Total assets $62,156  $60,069 
         
Current liabilities        
Accounts payable $5,289  $5,592 
Accrued expenses  2,587   2,196 
Accrued income taxes  1,215   653 
Total current liabilities  9,091   8,441 
Line of credit  2,774   2,768 
Operating lease liabilities  143   165 
Deferred income taxes, net  1,764   1,764 
Other long-term liabilities  160   77 
Total liabilities  13,932   13,215 
         
Commitments and contingencies        
         
Stockholders' equity        
Preferred stock, no par value; 2,500 shares authorized; no shares issued or outstanding at March 31, 2021 and December 31, 2020      
Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 15,604 outstanding at March 31, 2021 and December 31, 2020  6,509   6,509 
Paid-in capital  2,664   2,600 
Treasury stock, at cost  (12,450)  (12,450)
Retained earnings  51,501   50,195 
Total stockholders' equity  48,224   46,854 
         
Total liabilities and stockholders' equity $62,156  $60,069 

 

See accompanying notes to consolidated financial statements

 

 3 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)Operations

For the three months ended March 31, 2021 and nine months ended September 30, 2017 and 20162020

(Unaudited)

(In thousands, except per share data)

  

Three Months Ended

September 30,

  

Nine Months Ended

September 30,

 
  2017  2016  2017  2016 
             
Net sales $28,786  $29,990  $92,636  $93,691 
                 
Cost of goods sold  20,331   21,478   65,262   65,480 
Depreciation expense  618   533   1,801   1,797 
Total cost of goods sold  20,949   22,011   67,063   67,277 
                 
Gross profit  7,837   7,979   25,573   26,414 
                 
Selling expenses  4,010   4,306   11,648   10,733 
General and administrative  3,145   3,308   10,743   10,300 
Amortization expense  168   176   504   529 
Total operating expenses  7,323   7,790   22,895   21,562 
                 
Income from operations  514   189   2,678   4,852 
                 
Other income (expense):                
Interest expense  (62)  (56)  (180)  (161)
Gain (loss) on sale of investments, net reclassified from OCI     12      (15)
Loss on sale of property and equipment  (34)  (156)  (39)  (307)
Other income, net     28      105 
Total other income (expense)  (96)  (172)  (219)  (378)
                 
Income before provision for income taxes  418   17   2,459   4,474 
                 
Provision for income taxes  175   81   1,056   1,476 
                 
Net income (loss) $243  $(64) $1,403  $2,998 
                 
Earnings per common share:                
Basic $0.02  $0.00  $0.09  $0.19 
Diluted $0.02  $0.00  $0.09  $0.19 
                 
Weighted average common shares:                
Basic  16,093   16,141   16,133   16,159 
Diluted  16,168   16,161   16,218   16,181 
                 
COMPREHENSIVE INCOME (LOSS)                
                 
Net income (loss) $243  $(64) $1,403  $2,998 
                 
Other comprehensive income (loss), net of tax:                
Unrealized gains on investments, net of taxes     6      62 
Reclassifications to earnings:                
Realized (gains) losses on investments, net of taxes     (8)     9 
                 
Comprehensive income (loss) $243  $(66) $1,403  $3,069 

  2021  2020 
       
Net Sales $29,376  $25,388 
         
Cost of goods sold  20,512   18,624 
Depreciation expense  815   767 
Total cost of goods sold  21,327   19,391 
         
Gross profit  8,049   5,997 
         
Selling expense  3,222   2,575 
General and administrative expense  2,891   3,145 
Amortization expense     39 
Total operating expenses  6,113   5,759 
         
Income from operations  1,936   238 
         
Other income (expense):        
Interest expense  (22)  (39)
(Loss) gain on sale of property and equipment  (7)  5 
Other income, net  (8)  (3)
Total other income (expense)  (37)  (37)
         
Income before provision for income taxes  1,899   201 
         
Provision for income taxes  593   55 
         
Net income $1,306  $146 
         
Earnings per common share:        
Basic $0.08 $0.01 
Diluted $0.08 $0.01 
         
Weighted average common shares:        
Basic  15,604   15,623 
Diluted  15,814   15,737 

 

See accompanying notes to consolidated financial statements

 

 

 4 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Stockholders’ Equity

For the Nine Months Ended September 30, 2017 and 2016

(Unaudited)

(In thousands)

                 Accumulated    
                 Other    
  Common Stock        Comprehensive    
  Issued  In treasury  Paid-In  Retained  Income (Loss),  Total 
  Shares  $  Shares  $  Capital  Earnings  Net of Tax  Equity 
                         
Balance, January 1, 2016  17,274  $6,509   (1,064) $(9,730) $2,033  $46,516  $(71) $45,257 
                                 
Other comprehensive income                     71   71 
                                 
Treasury stock purchased        (69)  (738)           (738)
                                 
Stock-based compensation              100         100 
                                 
Net income                 2,998      2,998 
                                 
Balance, September 30, 2016  17,274  $6,509   (1,133) $(10,468) $2,133  $49,514  $  $47,688 
                                 
                                 
Balance, January 1, 2017  17,274  $6,509   (1,120) $(10,340) $2,198  $49,995  $  $48,362 
                                 
Treasury stock purchased        (117)  (1,187)           (1,187)
                                 
Stock-based compensation              49         49 
                                 
Net income                 1,403      1,403 
                                 
Balance, September 30, 2017  17,274  $6,509   (1,237) $(11,527) $2,247  $51,398  $  $48,627 

  Common Stock          
  Issued  In treasury  Paid-In  Retained  Total 
  Shares  $  Shares  $  Capital  Earnings  Equity 
                      
Balance, January 1, 2020  17,274  $6,509   (1,564) $(12,601) $2,380  $46,963  $43,251 
                             
Issuance of common stock in connection with stock-based compensation        27   210   306      516 
                             
Treasury stock purchased        (179)  (405)        (405)
                             
Stock-based compensation              62      62 
                             
Net loss                 146   146 
                             
Balance, March 31, 2020  17,274  $6,509   (1,716) $(12,796) $2,748  $47,109  $43,570 
                             
Balance, January 1, 2021  17,274  $6,509   (1,669) $(12,450) $2,600  $50,195  $46,854 
                             
Stock-based compensation              64      64 
                             
Net income                 1,306   1,306 
                             
Balance, March 31, 2021  17,274  $6,509   (1,669) $(12,450) $2,664  $51,501  $48,224 

 

 

See accompanying notes to consolidated financial statements

 

 

 5 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2017 and 2016

(Unaudited)

(In thousands)

 

  2017  2016 
       
Cash flows from operating activities:        
Net income $

1,403

  $2,998 
Adjustments to reconcile net income to operating cash flow:        
Depreciation and amortization  2,305   2,326 
Loss on sale of investments, net     15 
Reserve for inventory obsolescence  320   89 
Stock-based compensation  901   100 
Deferred income taxes     444 
Loss on sale of property and equipment  39   307 
(Increase) decrease in operating assets:        
Accounts receivable  (814)  (823)
Inventories  (328)  (1,611)
Refundable income taxes  (462)  (72)
Prepaid expenses and other current assets  (231)  (310)
Increase (decrease) in operating liabilities:        
Accounts payable  1,384   370 
Accrued expenses  252   465 
Accrued income taxes  (580)  215 
Net cash provided by operating activities  4,189   4,513 
         
Cash flows from investing activities:        
Purchases of investments  (25)  (559)
Proceeds from sale of investments     2,751 
Redemption of certificates of deposits     513 
Purchases of property and equipment  (3,932)  (2,481)
Proceeds from sale of property and equipment  37   149 
Net cash (used in) provided by investing activities  (3,920)  373 
         
Cash flows from financing activities:        
Purchase of treasury stock  (1,187)  (738)
Repayment of notes payable  (630)  (630)
Net cash used in financing activities  (1,817)  (1,368)
         
Net (decrease) increase in cash and cash equivalents  (1,548)  3,518 
         
Cash and cash equivalents at the beginning of the period  8,812   5,646 
         
Cash and cash equivalents at the end of the period $7,264  $9,164 
         
Supplemental cash flow information:        
Cash paid for income taxes, net of refunds $2,098  $886 
Cash paid for interest $180  $162 

  Three Months Ended March 31, 
  2021  2020 
Cash flows from operating activities:        
Net income $1,306  $146 
Adjustments to reconcile net income (loss) to operating cash flow:        
Depreciation and amortization  815   806 
Non-cash interest expense  6   6 
Non-cash rent expense     (11)
Bad debt expense     1 
Deferred revenue  (8)  (24)
Stock-based compensation  153   117 
Deferred income taxes     370 
Loss (gain) on sale of property and equipment  7   (5)
(Increase) decrease in operating assets:        
Accounts receivable  (1,959)  (1,739)
Inventories  193   (491)
Refundable income taxes  (15)  (346)
Prepaid expenses and other current assets  54   312 
Increase (decrease) in operating liabilities:        
Accounts payable  (301)  833 
Accrued expenses  398   (981)
Operating lease asset amortization/liability     (11)
Accrued income taxes  561   (38)
Net cash provided by (used in) operating activities  1,210   (1,055)
         
Cash flows from investing activities:        
Purchases of property and equipment  (518)  (403)
Proceeds from sale of property and equipment     5 
Net cash used in investing activities  (518)  (398)
         
Cash flows from financing activities:        
Purchase of treasury stock     (405)
Net cash used in financing activities     (405)
         
Net increase (decrease) in cash and cash equivalents  692   (1,858)
         
Cash and cash equivalents at the beginning of the period  7,926   3,836 
         
Cash and cash equivalents at the end of the period $8,618  $1,978 
         
Supplemental cash flow information:        
Cash paid for income taxes, net of (refunds) $47  $65 
Cash paid for interest $16  $35 
         
Non-cash investing activities        
Increase (decrease) in right-of-use assets and operating lease obligations $21  $113 
         
Non-cash financing activities        
Issuance of common stock under equity incentive plans $  $516 

 

See accompanying notes to consolidated financial statements

 

 

 6 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

September 30, 2017 and December 31, 2016

(Unaudited)

(In thousands, except per share data)

Note 1 – Basis of Presentation

 

Basis of presentation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) for interim financial information, and do not include all of the information and disclosures required for complete, audited financial statements. In the opinion of management, these statements include all adjustments consisting only of normal recurring adjustments, considered necessary for a fair presentation have been included. For further information, refer toof the results of all interim periods reported herein. The consolidated financial statements and related notes should be read in conjunction with the consolidated financial statements and disclosuresrelated notes included in Company’sour Annual Report on Form 10-K as of and for the fiscal year ended December 31, 2016. Certain amounts in prior-year financial statements were reclassified to conform to the current-year presentation. The results2020. Results of operations for the periodinterim periods are not necessarily indicative of the results to be expected for other interim periods or the full year.

A detailed description of our significant accounting policies can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

 

Principles of consolidation

 

Our consolidated financial statements include the accounts of Lifeway Foods, Inc. and all its wholly owned subsidiaries (collectively “Lifeway” or the “Company”). All significant intercompany accounts and transactions have been eliminated.

 

Note 2 – Significant Accounting Policies

 

Use of estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the consolidated financial statements include the reserve for promotional allowances, the valuation of goodwill and intangible assets, stock-based and incentive compensation, and deferred income taxes.

 

Revenue Recognitionrecognition

 

The Company records sales whenWe sell food and beverage products across select product categories to customers predominantly within the following four criteria have been met: (i) The product has been shippedUnited States (see Note 12, Segments, Products and the Company has no significant remaining obligations; (ii) Persuasive evidenceCustomers). We also sell bulk cream, a byproduct of an agreement exists; (iii) The price to the buyer is fixed or determinable; and (iv) Collection is probable. In addition, shipping costs invoiced to the customers are included in net sales and the related costs are included in cost of sales.

The Company routinely offers sales allowances and discounts to our customers and consumers. These programs include rebates, in-store display and demo allowances, allowances for non-salable product, coupons and other trade promotional activities. These allowances are considered reductions in the price of our products and thus are recorded as reductions to gross sales. Some of these incentives are recorded by estimating incentive costs based on our historical experience and expected levels of performance of the trade promotion. We maintain a reserve for the estimated allowances incurred but unpaid. Differences between estimated and actual allowances are normally insignificant and are recognized in income in the period such differences are determined. Product returns have historically not been material.

Bulk cream is a by-product of the Company’s fluid milk manufacturing process. In accordance with ASC 606, Revenue from Contracts with Customers, we recognize revenue when control over the products transfers to our customers, which generally occurs upon delivery to our customers or their common carriers. The amount of revenue recognized reflects the consideration to which the Company does not use its by-product bulk creamexpects to be entitled to receive in any of its end products, but rather disposes of it through sales to other companies. Bulk cream by-product sales are included in net sales.exchange for these goods or services, using the five-step method required by ASC 606.

 

AdvertisingFor the Company, the contract is the approved sales order, which may also be supplemented by other agreements that formalize various terms and promotional costsconditions with customers. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer.

 

The Company expenses advertising costs as incurred. ForPerformance obligations promised in a contract are identified based on the nine months ended September 30, 2017 and 2016 total advertising expenses were $4,703 and $5,418 respectively. Forgoods or services that will be transferred to the three months ended September 30, 2017 and 2016 total advertising expenses were $1,892 and $2,665 respectively.

customer, which is the delivery of food products which provide immediate benefit to the customer.

 

 

 7 

 

 

We account for product shipping and handling as fulfillment activities with revenues for these activities recorded within net revenue and costs recorded within cost of goods sold. Any taxes collected on behalf of government authorities are excluded from net revenues.

Variable consideration, which typically includes volume-based rebates, known or expected pricing or revenue adjustments, such as trade discounts, allowances for non-saleable products, product returns, trade incentives and coupon redemption, is estimated utilizing the most likely amount method.

Key sales terms, such as pricing and quantities ordered, are established on a frequent basis such that most customer arrangements and related incentives have a one year or shorter duration. As such, we do not capitalize contract inception costs and we capitalize product fulfillment costs in accordance with U.S. GAAP and our inventory policies. We do not have any significant deferred revenue or unbilled receivables at the end of a period. We generally do not receive noncash consideration for the sale of goods, nor do we grant payment financing terms greater than one year.

Recently Adopted Accounting PronouncementsAdvertising and promotional costs

 

InLifeway expenses advertising costs as incurred. For the three months ended March 2016, the Financial Accounting Standards Board ("FASB") issued ASU No. 2016-09, Compensation-Stock Compensation – Improvements to Employee Share-Based Payment Accounting. The new guidance simplifies several aspects of the accounting for employee share-based payment transactions, including the accounting for income taxes, forfeitures, statutory tax withholding requirements, classification of awards as either equity or liabilities,31, 2021 and classification in the statement of cash flows. Under this ASU, excess tax benefits2020 total advertising expenses were $1,393 and deficiencies are no longer recognized as additional paid-in capital in the consolidated balance sheets. This guidance was effective on January 1, 2017. The adoption of this amendment had no impact on the consolidated financial statements.$536 respectively.

 

Recent accounting pronouncements

Adopted

In November 2015,December 2019, the FASB issued ASU 2015-17,Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes – Balance Sheet Classification of Deferred Taxes. This new guidance simplifies the presentation of deferred income taxes and requires that all deferred tax assets and liabilities, along with any related valuation allowance, be classified as noncurrent on the balance sheet. Previous guidance required deferred tax assets and liabilities to be separated into current and noncurrent amounts on the balance sheet. This guidance was effective on January 1, 2017. The Company elected to adopt this guidance as of the first fiscal quarter in 2017 and has applied the update on a retrospective basis. The Company changed its accounting principle to reduce the cost and complexity inherent in recording deferred taxes as current and noncurrent on the consolidated balance sheets. As a result, the Company has reclassified $662 of current deferred tax asset to noncurrent deferred tax liability in the consolidated balance sheet as of December 31, 2016.

In July 2015, the FASB issued ASU 2015-11, Inventory –(Topic 740): Simplifying the Measurement of Inventory. The core principal of the guidance is that an entity should measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. This guidance was effective on January 1, 2017. The adoption of this amendment had no impact on the consolidated financial statements.

Recently Issued Accounting Pronouncements

In May 2017, the FASB issued ASU No. 2017-09, Compensation – Stock Compensation (Topic 718): Scope of Modification Accounting. The new guidance provides clarity and reduces both diversity in practice and cost of complexity when accounting for a change to the terms of or conditions of a share-based payment award. The amendments in this Update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The new guidance will be effective for fiscal years beginning on or after December 15, 2017 and interim periods within those years. Early adoption of the guidance is permitted. The adoption of this amendment is not expected to have a material impact on the consolidated financial statements.

In January 2017, the FASB issued ASU No. 2017-04, Intangibles - Goodwill and Other: Simplifying the Test for Goodwill Impairment. The new guidance simplifies the subsequent measurement of goodwill by removing the second step of the two-step impairment test. The amendment requires an entity to perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The new guidance will be effective for annual periods or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. The amendment should be applied on a prospective basis. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The adoption of this amendment is not expected to have a material impact on the consolidated financial statements.

In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments.Income Taxes. The new guidance is intended to addressenhance and simplify various aspects of the diversityaccounting for income taxes. The new guidance eliminates certain exceptions to the general approach to the income tax accounting model and adds new guidance to reduce the complexity in practice in how certain cash receiptsaccounting for income taxes. The Company adopted this guidance on January 1, 2021. The adoption of this standard did not have a material impact on our consolidated financial statements and cash payments are presenteddisclosures.

Issued but not yet effective

In March 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The new guidance provides optional expedients and classified in the statement of cash flows, such as debt prepayment or debt extinguishment costs, contingent consideration payments made after an acquisition, proceeds from the settlement of insurance claims,exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other topics.transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The new guidance will be effective for fiscal years beginning on or afterprospectively as of March 12, 2020 through December 15, 201731, 2022 and interim periods within those fiscal years. Early adoption of the guidance is permitted. Management is currently evaluating the impact that the new guidance will have on the consolidated financial statements.

 

In FebruaryJune 2016, the FASB issued ASU No. 2016-02, Leases.2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, in November 2018 issued an amendment, ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, and in November 2019 issued two amendments, ASU 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates, and ASU 2019-11, Codification Improvements to Topic 326, Financial Instruments—Credit Losses. The series of new guidance amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. The guidance requires lessees to recognize lease assets and lease liabilities inshould be applied on either a prospective transition or modified-retrospective approach depending on the balance sheet and disclose key information about leasing arrangements, such as information about variable lease payments and options to renew and terminate leases.subtopic. The amended guidance will require both operating and finance leases to be recognized in the balance sheet. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. The new guidance is effective for financial statements issued for fiscal yearsannual periods beginning after December 15, 2018, and2022, including interim periods within those years. Earlyfiscal years, with early adoption is permitted. The amendments in this ASU should be adopted using a modified retrospective transition approach, which requires application of the new guidance at the beginning of the earliest comparative period presented in the year of adoption. We do not intend to early adopt the standard. Management is currently evaluating the impact that the new guidance will have on the consolidated financial statements.

8

In January 2016, the FASB issued ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities. The new guidance modifies how entities measure equity investments and present changes in the fair value of financial liabilities. Under the new guidance, entities will have to measure equity investments that do not result in consolidation and are not accounted under the equity method at fair value and recognize any changes in fair value in net income unless certain conditions exist. The new guidance will be effective for fiscal years beginning on or after December 15, 2017 and interim periods within those years. Early adoption of the guidance is not permitted. The adoption of this amendment is not expected to have an impact on the consolidated financial statements.

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASU 2014-09"), which supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, including most industry-specific requirements. ASU 2014-09 establishes a five-step revenue recognition process in which an entity will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The standard allows for either “full retrospective” adoption, meaning the standard is applied to all of the periods presented, or “modified retrospective” adoption, meaning the standard is applied only to the most current period presented in the financial statements. ASU 2014-09 also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenues and cash flows from contracts with customers. On August 12, 2015, the FASB approved a one year delay of the effective date to reporting periods beginning after December 15, 2017, while permitting companies to voluntarily adopt the new standard as of the original effective date. In December 2016, the FASB issued ASU No. 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers, which clarifies narrow aspects of ASC 606 or corrects unintended application of the guidance. The effective date and transition requirements for ASU 2016-20 are the same as the effective date and transition requirements for ASU 2014-09. Under the delayed effective date, the Company is required to adopt the new standard not later than January 1, 2018.

Management is currently evaluating the impact the adoption of this amendment will have on the Company's consolidated financial position, results of operations or cash flows and the method of retrospective application, either full or modified. Our completed evaluation will include the impact of the new standard on certain common practices currently employed by us, such as rebates, in-store display and demo allowances, allowances for non-saleable product, and coupons. We currently expect to utilize the modified retrospective transition method and to adopt the ASU on January 1, 2018. Based on our findings to date, we do not expect the standard to have a material impact on our results of operations or financial position; however, our assessment is not yet complete. During 2017, we plan to finalize our review and method of adoption.

 

Note 3 – Inventories, net

 

Inventories consisted of the following:

 

 September 30,
2017
  December 31,
2016
  March 31,
2021
  December 31,
2020
 
Ingredients $2,056  $2,256  $1,684  $1,725 
Packaging  2,789   2,770   2,114   2,234 
Finished goods  3,205   3,016   2,938   2,971 
Total inventories $8,050  $8,042  $6,736  $6,930 

8

 

Note 4 – Property, Plant and Equipment, net

 

Property, plant and equipment consisted of the following:

 

  September 30,
2017
  December 31,
2016
 
Land $1,747  $1,747 
Buildings and improvements  17,052   16,428 
Machinery and equipment  26,625   23,122 
Vehicles  861   848 
Office equipment  734   709 
Construction in process  1,454   1,873 
   48,473   44,727 
Less accumulated depreciation  (24,585)  (22,895)
Total property, plant and equipment, net $23,888  $21,832 

9

  March 31,
2021
  December 31,
2020
 
Land $1,565  $1,565 
Buildings and improvements  17,182   17,834 
Machinery and equipment  31,716   31,707 
Vehicles  778   778 
Office equipment  862   857 
Construction in process  587   228 
   52,690   52,969 
Less accumulated depreciation  (31,946)  (31,921)
Total property, plant and equipment, net $20,744  $21,048 

 

Note 5 – Goodwill and Intangible Assets

 

Goodwill &and indefinite-lived intangible assets consisted of the following:

 

 September 30,
2017
  December 31,
2016
  March 31,
2021
  December 31,
2020
 
Gross goodwill $10,368  $10,368 
Accumulated impairment losses  (1,244)  (1,244)
Goodwill $10,368  $10,368   9,124   9,124 
Brand names  3,700   3,700   3,700   3,700 
Goodwill and indefinite-lived intangible assets $14,068  $14,068  $12,824  $12,824 

Finite-lived Intangible Assets

 

Other intangible assets, net consisted of the following:

 

 September 30,
2017
  December 31,
2016
  March 31,
2021
  December 31,
2020
 
Recipes $44  $44  $44  $44 
Customer lists and other customer related intangibles  4,529   4,529   4,529   4,529 
Customer relationship  985   985   985   985 
Trade names  2,248   2,248   2,248   2,248 
Formula  438   438   438   438 
  8,244   8,244   8,244   8,244 
Accumulated amortization  (7,101)  (6,597)  (8,244)  (8,244)
Other intangible assets, net $1,143  $1,647  $  $ 

9

 

Note 6 – Accrued Expenses

 

Accrued expenses consisted of the following:

 

 September 30,
2017
  

December 31,

2016

  March 31,
2021
  

December 31,

2020

 
Payroll and incentive compensation $2,318  $1,560  $1,825  $1,366 
Real estate taxes  301   394   271   341 
Current portion of operating lease liabilities  174   179 
Other  247   215   317   310 
 $2,866  $2,169 
Total accrued expenses $2,587  $2,196 

 

Note 7 – Notes PayableDebt

 

  

September 30,

2017

  

December 31,

2016

 
       
Variable rate term loan due May 31, 2018. Principal and interest (3.74% at September 30, 2017) payable monthly with a balloon payment due at maturity. $2,959  $3,339 
         
Variable rate term loan due May 31, 2019. Principal and interest (3.74% at September 30, 2017) payable monthly with a balloon payment due at maturity.  3,530   3,780 
Total notes payable  6,489   7,119 
Less current portion  (3,292)  (840)
Total long-term portion $3,197  $6,279 

Line of Credit

 

On May 7, 2018, Lifeway entered into an Amended and Restated Loan and Security Agreement (the “Revolving Credit Facility”) with its existing lender. On April 10, 2019, effective March 31, 2019, Lifeway entered into the First Modification to the Amended and Restated Loan and Security Agreement (the “Modified Revolving Credit Facility”) with its existing lender. Under the amendment, the Modified Revolving Credit Facility provides for a revolving line of credit up to a maximum of $9 million (the “Revolving Loan”) with an incremental facility not to exceed $5 million (the “Incremental Facility” and together with the Revolving Loan, the “Loans”).

On December 10, 2019, Lifeway entered into the Second Modification to the Amended and Restated Loan and Security Agreement, as amended, (the “Second Modification”) with its existing lender. The variable rate termSecond Modification amends the Amended and Restated Loan and Security Agreement, as amended, by redefining the “Borrowing Base” and further clarifying the definitions of “Eligible Accounts” and “Eligible Inventory.” The “Borrowing Base” under this amendment means, generally, an amount equal to the sum of (a) 85% of the unpaid amount of all eligible accounts receivable, plus (b) 50% of the value of all eligible inventory. The Second Modification also addresses the calculation of interest after the potential discontinuance of LIBOR and its replacement with a replacement benchmark interest rate.

On September 30, 2020, Lifeway entered into the Third Modification to the Amended and Restated Loan and Security Agreement, as amended, (the “Third Modification”) with its existing lender. The Third Modification amends the Amended and Restated Loan and Security Agreement, as amended, by removing the monthly borrowing base reporting requirement effective September 30, 2020, including a covenant to maintain a quarterly minimum working capital financial covenant, as defined, of no less than $11.25 million each of the fiscal quarters commencing the fiscal quarter ending December 31, 2020 through the expiration date, and eliminating the tier interest pricing structure. The Amended and Restated Loan and Security Agreement continues to provide Lifeway with a revolving line of credit up to a maximum of $5 million (the “Revolving Loan”) and provides the Borrowers with an incremental facility not to exceed $5 million (the “Incremental Facility” and together with the Revolving Loan, the “Loans”). The Termination Date of the Revolving Loan was extended to June 30, 2025, unless earlier terminated.

Except as described above, as amended, the Modified Revolving Credit Facility remains substantively unchanged and in full force and effect, including customary representations, warranties, and covenants on the part of Lifeway, including financial covenants requiring us to maintain a fixed charge coverage ratio of no less than 1.25 to 1.00 each of the fiscal quarters ending through the expiration date. The Modified Revolving Credit Facility continues to provide for events of default, including failure to repay principal and interest when due and failure to perform or violation of the provisions or covenants of the agreement, as a result of which amounts due under the Modified Revolving Credit Facility may be accelerated. The loans and all other amounts due and owed under the Revolving Credit Facility and related documents are subject to interest at the prime rate or at the LIBOR rate plus 2.5% and are collateralizedsecured by substantially all of the assetsour assets.

As of the Company. In addition,March 31, 2021, we had $2,774 net of $3 of unamortized deferred financing costs, outstanding under the termsRevolving Credit Facility. We had $2,223 available for future borrowings as of the related agreements, the Company is subject to minimum fixed charged ratio and tangible net worth thresholds, which among other things may limit the Company's ability to pay dividends or repurchase shares of its common stock. Further, under the agreements the Company is required to deliver its annual and quarterly financial statements and related SEC filings within specified timeframes. The Company was in compliance with these financial covenants at September 30, 2017.

In addition, the Company has a $5 million revolving credit facility. Borrowings under the facility are subject to interest at the prime rate or LIBOR plus 2.5%. As of September 30, 2017 there were no borrowings under the facility. The facility expires in July 2018.March 31, 2021.

 

 

 10 

 

As amended, all outstanding amounts under the Loans bear interest, at Lifeway’s election, at either the lender Base Rate (the Prime Rate minus 1.00%) or the LIBOR plus 1.95%, payable monthly in arrears. Lifeway is also required to pay a quarterly unused line fee of 0.20% and, in conjunction with the issuance of any letters of credit, a letter of credit fee of 0.20%. Lifeway’s interest rate on debt outstanding under our Revolving Credit Facility as of March 31, 2021 was 2.15%.

We were in compliance with the fixed charge coverage ratio and minimum working capital covenants at March 31, 2021.

Note 8 – Leases

Lifeway has operating leases for two retail stores for its Lifeway Kefir Shop subsidiary which includes fixed base rent payments as well as variable rent payments to reimburse the landlord for operating expenses and taxes. The Company terminated its office space leases in June 2020. The Company also lease certain machinery and equipment with fixed base rent payments and variable costs based on usage. Remaining lease terms for these leases range from less than 1 year to 4 years. Some of our leases include options to extend the leases for up to 5 years and have been included in our calculation of the right-of-use asset and lease liabilities. Lifeway includes only fixed payments for lease components in the measurement of the right-of-use asset and lease liability. Variable lease payments are those that vary because of changes in facts or circumstances occurring after the commencement date, other than the passage of time. There are no residual value guarantees. We do not currently have leases which meet the finance lease classification as defined under ASC 842.

We do not record leases with an initial term of 12 months or less on the balance sheet. Expense for these short-term leases is recorded on a straight-line basis over the lease term. Total lease expense was $78 and $179 (including short term leases) for the three months ended March 31, 2021 and 2020, respectively.

Lifeway treats contracts as a lease when the contract conveys the right to use a physically distinct asset for a period of time in exchange for consideration, we direct the use of the asset and obtain substantially all the economic benefits of the asset.

Right-of-use assets and lease liabilities are measured and recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. We have elected the practical expedient to combine lease and non-lease components into a single component for all of its leases. For many of our leases such as real estate leases, we are unable to determine an implicit rate; therefore, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments for those leases. We include options to extend or terminate the lease in the measurement of the right-of-use asset and lease liability when it is reasonably certain that we will exercise such options. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.

Future maturities of lease liabilities were as follows

Year Operating Leases 
Nine months ended December 31, 2021 $147 
2022  158 
2023  23 
2024  7 
2025  5 
Thereafter  2 
Total lease payments  342 
Less: Interest  (26)
Present value of lease liabilities $316 

The weighted-average remaining lease term for our operating leases was 2.05 years as of March 31, 2021. The weighted average discount rate of our operating leases was 7.85% as of March 31, 2021. Cash paid for amounts included in the measurement of lease liabilities was $55 and $142 for the three months ended March 31, 2021 and 2020, respectively.

11

 

Note 89 – Commitments and contingencies

 

Lease obligationsLitigation

 

The Company leases three retail stores for its Lifeway Kefir Shop subsidiary, certain machinery and equipment, and office space under operating leases. Total lease expense was $497 and $331 for the nine months ended September 30, 2017 and 2016, respectively. Total lease expense was $175 and $171 for the three months ended September 30, 2017 and 2016, respectively.

Litigation

The Company is engaged in various legal actions, claims, audits, and proceedings arising in the normal course of business, including commercial disputes, product liabilities, intellectual property matters and employment-related matters resulting from the Company’sour business activities.

 

The Company recordsWe record accruals for outstanding legal matters when it believeswe believe it is probable that a loss will be incurred and the amount of such loss can be reasonably estimated. The Company evaluates,We evaluate, on a periodic basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and estimable, the Company doeswe do not establish an accrued liability. Currently, none of the Company’sour accruals for outstanding legal matters are material individually or in the aggregate to the Company’sour financial position and it is management’s opinion that the ultimate resolution of these outstanding legal matters will not have a material adverse effect on our business, financial condition, results of operations, or cash flows. However, if the Companywe ultimately isare required to make payments in connection with an adverse outcome, it is possible that it could have a material adverse effect on the Company’sour business, financial condition, results of operations or cash flows.

 

The Company’sLifeway’s contingencies are subject to substantial uncertainties, including for each such contingency the following, among other factors: (i) the procedural status of the case; (ii) whether the case has or may be certified as a class action suit; (iii) the outcome of preliminary motions; (iv) the impact of discovery; (v) whether there are significant factual issues to be determined or resolved; (vi) whether the proceedings involve a large number of parties and/or parties and claims in multiple jurisdictions or jurisdictions in which the relevant laws are complex or unclear; (vii) the extent of potential damages, which are often unspecified or indeterminate; and (viii) the status of settlement discussions, if any, and the settlement posture of the parties. Consequently, the CompanyLifeway cannot predict with any reasonable certainty the timing or outcome of such contingencies, and the Company iswe are unable to estimate a possible loss or range of loss.

 

In a letter dated May 19, 2016, the Company received a request to voluntarily produce documents in connection with a confidential, informal inquiry by the Division of Enforcement of the SEC concerning the Company’s internal controls, disclosure controls procedures, and internal control over financial reporting for fiscal years 2013 through the date of the letter. The SEC has informed the Company that the inquiry should not be construed as an indication that any violation of any federal securities law has occurred or as a reflection upon the merits of any person, company, or securities involved. Since receiving the letter, the Company has been cooperating with the SEC and will continue to do so.

Note 910 – Income taxes

 

For each interim period, the CompanyLifeway estimates the effective tax rate (“ETR”) expected to be applicable for the full year and applies that rate to income before provision for income taxes for the period. Additionally,The effective tax rate for the Company recordsthree months ended March 31, 2021 was 31.2% compared to 27.5% for the three months ended March 31, 2020. Our effective tax rate may change from period to period based on recurring and non-recurring factors including the relative mix of pre-tax earnings (or losses), the underlying income tax rates applicable to various state and local taxing jurisdictions, enacted tax legislation, the impact of non-deductible items, changes in valuation allowances, and the expiration of the statute of limitations in relation to unrecognized tax benefits. We record discrete income tax items such as enacted tax rate changes and completed tax audits in the period in which they occur.

  

On March 27, 2020, the “Coronavirus Aid, Relief, and Economic Security Act” (the CARES Act) was enacted. The effectiveCARES act features several tax rateprovisions and other measures that assist businesses impacted by the economic effects of the COVID-19 pandemic. The significant tax provisions include an increase in the limitation of the tax deduction for interest expense from 30% to 50% of adjusted earnings in 2019 and 2020, a five-year carryback allowance for net operating losses generated in tax years 2018-2020, increased charitable contribution limitations to 25% of taxable income in 2020, and a retroactive technical correction to the 2017 Tax Cuts and Jobs Act that makes qualified improvement property placed in service after December 31, 2017 eligible for bonus depreciation. The Company has recorded a $245 income tax benefit related to the net operating loss carryback provisions of the CARES Act for the three months ended September 30, 2017 was 41.9% compared to over 100.0% for the three months ended September 30, 2016. The effective tax rate for the nine months ended September 30, 2017 was 42.9% compared to 33.0% for the nine months ended September 30, 2016.March 31, 2020.

 

Note 10 – Fair Value Measurements

Unrecognized tax benefits were $96 and $90 at March 31, 2021 and 2020, respectively. We do not expect material changes to our unrecognized tax benefits during the next twelve months. The Company’s financial assets and liabilities include cash and cash equivalents, accounts receivable, accounts payable and notes payable, and are reported at carrying value which approximates fair value.Company believes that an adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If a tax audit is resolved in a manner inconsistent with its expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. We do not expect material changes to our unrecognized tax benefits during the next twelve months.

 

 

 1112 

 

 

Note 11 – Stock-based and Other Compensation

 

Stock Options

In December 2015, Lifeway shareholdersstockholders approved the 2015 Omnibus Incentive Plan, which authorized the issuance of an aggregate of 3.5 million shares to satisfy awards of stock options, stock appreciation rights, unrestricted stock, restricted stock, restricted stock units, performance shares and performance units.units to qualifying employees. Under the Plan, the Board or its Audit and Corporate Governance Committee approves stock awards to executive officers and certain senior executives, generally in the form of restricted stock or performance shares. The number of performance shares that participants may earn depends on the extent to which the corresponding performance goals have been achieved. Stock awards generally vest over a three-year performance or service period. At September 30, 2017, 3.448March 31, 2021, 3.317 million shares remain available under the Omnibus Incentive Plan. The Company has not established a pace forWhile we plan to continue to issue awards pursuant to the frequency of awards under the Omnibus Incentive Plan andat least annually, we may choose to suspend the issuance of new awards in the future and may grant additional awards at any time including issuing special grants of restricted stock, restricted stock units, and stock options to attract and retain new and existing executives.

 

Stock Options

The following table summarizes stock option activity during the ninethree months ended September 30, 2017:March 31, 2021:

 

 Options Weighted
average
exercise price
 Weighted
average
remaining contractual life
 Aggregate
intrinsic value
  Options  Weighted
average
exercise price
  Weighted
average
remaining contractual life
  Aggregate
intrinsic value
 
                  
Outstanding at December 31, 2016 45 $10.45      
Outstanding at December 31, 2020  41  $10.42   5.22  $ 
Granted  $                 
Exercised  $                 
Forfeited   $                 
Outstanding at September 30, 2017  45 $10.45 8.50 $(70)
Exercisable at September 30, 2017 29 $10.42 8.50 $(44)
Outstanding at March 31, 2021  41  $10.42   4.97  $ 
Exercisable at March 31, 2021  41  $10.42     $ 

   

As of December 31, 2019, all outstanding options were vested and there was no remaining unearned compensation expense.

Restricted Stock Awards

A Restricted Stock Award (“RSA”) represents the right to receive one share of common stock in the future. RSAs have no exercise price. The grant date fair value of the awards is equal to our closing stock price on the grant date. The following table summarizes RSA activity during the three months ended March 31, 2021.

  RSA’s 
    
Outstanding at December 31, 2020  78 
Granted  4 
Shares issued upon vesting   
Forfeited   
Outstanding at March 31, 2021  82 
Weighted average grant date fair value per share outstanding $3.04 

We expense RSA’s over the service period. For the ninethree months ended September 30, 2017March 31, 2021 and 20162020 total pre-tax stock-based compensation expense recognized in the consolidated statements of incomeoperations was $36 and comprehensive income was $35 and $100, respectively. For the nine months ended September 30, 2017 and 2016 tax-related benefits of $14 and $37 were also recognized. For the three months ended September 30, 2017 and 2016 total pre-tax stock-based compensation expense recognized in the consolidated statements of income and comprehensive income was $6 and $58,$5, respectively. For the three months ended September 30, 2017March 31, 2021 and 20162020 tax-related benefits of $3$11 and $22$1, respectively, were also recognized. As of September 30, 2017,March 31, 2021, the total remaining unearned compensation related to non-vested stock optionsRSA’s was $25,$108, which is expected to be amortized over the weighted-average remaining service period of 1.22 years.

 

We measure the fair value of stock options using the Black-Scholes option pricing model. The expected term of options granted was based on the weighted average time of vesting and the end of the contractual term. We utilized this simplified method as we do not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term.

Restricted Stock Units

Pursuant to the 2015 Omnibus Incentive Plan, Lifeway granted 2 Restricted Stock Units (“RSUs”) to certain key employees in December 2016. An RSU represents the right to receive one share of common stock in the future. RSUs have no exercise price.

The following table summarizes RSU activity during the nine months ended September 30, 2017:

  RSU’s 
    
Outstanding at December 31, 2016  2 
Granted   
Shares issued upon vesting   
Forfeited   
Outstanding at September 30, 2017  2 
Weighted average grant date fair value per share $10.54 

 1213 

 

 

We expense RSU’s over the service period. For the nine months ended September 30, 2017 and 2016 total pre-tax stock-based compensation expense recognized in the consolidated statements of income and comprehensive income was $14 and $0, respectively. For the nine months ended September 30, 2017 and 2016 tax-related benefits of $6 and $0 were also recognized. For the three months ended September 30, 2017 and 2016 total pre-tax stock-based compensation expense recognized in the consolidated statements of income and comprehensive income was $5 and $0, respectively. For the three months ended September 30, 2017 and 2016 tax-related benefits of $2 and $0 were also recognized. As of September 30, 2017, the total remaining unearned compensation related to non-vested RSU’s was $6, which is expected to be amortized over the weighted-average remaining service period of 0.71 years.Long-Term Incentive Plan Compensation

 

Incentive Compensation

In March 2016 Lifeway established anlong-term incentive-based compensation programprograms for fiscal year 2017 (the “2016“2017 Plan”) and for fiscal year 2019 (the “2019 Plan”) for certain senior executives and key employees (the “participants”). TheUnder both the 2017 Plan, long-term incentive compensation wasis based on theLifeway’s achievement of certain sales and adjusted EBITDA performance levels versus respective targets in 2016.established by the Board for each fiscal year. Under the 20162019 Plan, long-term equity incentive compensation is based on Lifeway’s achievement of four strategic milestones over a three-year period from Fiscal 2019 through Fiscal 2021.

2017 Plan

Under the senior executives2017 Plan, collectively the participants had the opportunity to earn cash and equity-based incentive compensation in amounts ranging from $0 to $4,000 for fiscal 2016 depending on the performance levels compared to the respective targets. For the nine months and three months ended September 30, 2016, bonuses of $1,280 and $240 were expensed under the 2016 Plan, respectively.

In January 2017, Lifeway established an incentive-based compensation program (the “2017 Plan”) for certain senior executives and key employees (the “participants”). The number of participants under the 2017 Plan was expanded from the 2016 Plan. Under the 2017 Plan, incentive compensation is based on (a) the achievement of certain sales and EBITDA performance levels versus respective targets in 2017, and (b) for certain senior executives, the achievement of individual performance objectives. Under the 2017 Plan, collectively the participants may earn cash and equity based incentive compensation in amounts ranging from $0 to $11,025 depending on the Company’sLifeway’s performance levels compared to the respective targets and the senior executive’sparticipants performance compared to their individual objectives. The equity portion of the incentive compensation is payable in restricted stock that vests one-third in each of the three years from the 2017 grant dates. For the ninethree months ended September 30, 2017, $2,106March 31, 2021 and 2020, $0 and $49 was accrued under the 2017 Plan, of which $1,254 was recorded as cash bonus expense and $852 was recordedexpensed as stock-based compensation expense in the consolidated statements of incomeoperations, respectively. As of March 31, 2021, there was no remaining expense.

2019 Plan

Under the 2019 Plan, collectively the participants can earn equity-based incentive compensation in amounts ranging from $0 to $1,776 depending on Lifeway’s performance levels compared to the respective targets. The equity-based incentive compensation is payable in restricted stock that vests 50% of unvested shares in year one, 50% of unvested shares in year two, and comprehensive income.100% of remaining unvested shares in year three from the 2019 grant date. For the three months ended September 30, 2017, $121March 31, 2021 and 2020, $19 and $13 was accrued under the 2017 Plan, of which $6 was recorded as cash bonus expense and $115 was recordedexpensed as stock-based compensation expense in the consolidated statements of incomeoperations, respectively.

2019 Retention Award

During Q1 2019, we awarded a special retention grant (the “2019 Retention Award”) of restricted stock to certain senior executives and comprehensive income.key employees (the “participants”). The equity-based incentive compensation is payable in restricted stock that vests one-third in March 2019, one-third in March 2020 and one-third in March 2021. For the three months ended March 31, 2021 and 2020, $8 and $43 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively. As of March 31, 2021, there was no remaining expense.

2020 CEO Incentive Award

During the fourth quarter 2020, we awarded a long-term equity-based incentive of $750 to our Chief Executive Officer (the “2020 CEO Award”) depending on Lifeways 2020 performance levels compared to the respective targets. The equity-based incentive compensation is payable in restricted stock that vests one-third in April 2022, one-third in April 2023, and one-third in April 2024. The issuance of vested equity awards is subject to approval under the Stock Purchase Agreement dated October 1, 1999. For the three months ended March 31, 2021 and 2020, $90 and $0 was expensed as stock-based compensation expense in the consolidated statements of operations, respectively. As of March 31, 2021, the total remaining unearned compensation was $610, of which $274 will be recognized in 2021, $221 in 2022, $98 in 2023, and $17 in 2024, respectively, subject to vesting.

 

Retirement Benefits

 

The CompanyLifeway has a defined contribution plan which is available to substantially all full-time employees. Under the terms of the plan, the Company matcheswe match employee contributions under a prescribed formula. For the ninethree months ended September 30, 2017March 31, 2021 and 20162020 total contribution expense recognized in the consolidated statements of incomeoperations was $113 and comprehensive income was $296 and $255,$118, respectively. For the three months ended September 30, 2017 and 2016 total contribution expense recognized in the consolidated statements of income and comprehensive income was $59 and $82, respectively.

14

 

Note 12 – Segments, Products and Customers

 

The Company manufactures probiotic, cultured, functional dairy health food products. The Company'sLifeway’s primary product is drinkable kefir, a cultured dairy beverage similarproduct. Lifeway Kefir is tart and tangy, high in protein, calcium and vitamin D. Thanks to but distinct from yogurt, in several flavorsour exclusive blend of kefir cultures, each cup of kefir contains 12 live and in several package configurations. In additionactive cultures and 25 to 30 billion beneficial CFU (Colony Forming Units) at the drinkable products, Lifeway manufactures "Lifeway Farmer Cheese," a linetime of various farmer cheeses.manufacture.

 

The CompanyWe manufacture (directly or through co-packers) and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of certain customers.

Our product categories are:

·Drinkable Kefir, sold in a variety of organic and non-organic sizes, flavors, and types, including low-fat, non-fat, whole milk, protein, and BioKefir (a 3.5 oz. kefir with additional probiotic cultures).
·European-style soft cheeses, including farmer cheese, white cheese, and Sweet Kiss.
·Cream and other, which consists primarily of cream, a byproduct of making our kefir.
·ProBugs, a line of kefir products designed for children.
·Other Dairy, which includes Cupped Kefir and Icelandic Skyr, a line of strained kefir and yogurt products in resealable cups.
·Frozen Kefir, available in soft serve and pint-size containers.

Lifeway has determined that it has one reportable segment based on how the Company'sour chief operating decision maker manages the business and in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating decision maker, who is responsible for allocating resources and assessing Companyour performance, has been identified collectively as the Chief Financial Officer, the Chief Operating Officer, the Chief Executive Officer, and Chairperson of the board of directors. Substantially all of theour consolidated revenues of the Company relate to the sale of fermentedcultured dairy products which are producedthat we produce using the same processes and materials and are sold to consumers through a common network of distributors and retailers in the United States.

  

13

Net sales of products by category were as follows:follows for the three months ended March 31:

 

  Three months ended
September 30,
  Nine months ended
September 30,
 
  2017  2016  2017  2016 
Drinkable Kefir (a) $25,134  $25,533  $80,382  $80,135 
Lifeway cheese products  2,561   2,479   7,750   7,579 
Pro Bugs Kefir products  819   1,606   3,586   4,962 
Frozen Kefir  272   372   918   1,015 
Net Sales $28,786  $29,990  $92,636  $93,691 

  2021  2020 
  $  %  $  % 
Drinkable Kefir other than ProBugs $24,203   82%  $19,857   78% 
Cheese  3,199   11%   3,260   13% 
Cream and other  863   3%   781   3% 
ProBugs Kefir  680   2%   860   3% 
Other dairy  384   1%   371   2% 
Frozen Kefir (a)  47   1%   259   1% 
Net Sales $29,376   100%  $25,388   100% 

 

(a)Excludes ProBugsIncludes Lifeway Kefir products, and includes cream, cupped Kefir and cupped cheese products, supplements and other.Shop sales

 

Significant Customers – Sales are predominately to companies in the retail food industry located within the United States. Two major customers accounted for approximately 22% and 23% of net sales for the nine months ended September 30, 2017 and 2016, respectively, and 21% and 22% of net sales for the three months ended September 30, 2017March 31, 2021 and 2016,2020, respectively.

15

 

Note 13 – Related party transactionsParty Transactions

 

The CompanyLifeway obtains consulting services from the Chairperson of its board of directors. Fees earnedOn December 28, 2020, Lifeway entered into an amended and restated consulting agreement (the “Agreement”), effective as of December 31, 2020, with the Chairperson. Under the terms and conditions of the Agreement, the Chairperson will continue to provide consulting services with respect to, among other things, our business strategy, international expansion and product management and expansion. For the services, the Company will pay an annual service fee of $500. The Chairperson will also be eligible for an annual performance fee target of $500 based on the achievement of specified performance criteria. The Chairpersons annual service fee and target bonus amounts are subject to periodic change by the ChairpersonCompensation Committee of the Company’s Board of Directors on 30 days’ prior written notice to the Chairperson. The Agreement shall continue until either party provides at least a 10-day written notice of termination.

Service fees earned are included in general and administrative expenses in the accompanying consolidated statements of income and comprehensive incomeoperations and were $750 and $787 during the nine months ended September 30, 2017 and 2016, respectively,$125 and $250 and $248 during each of the three months ended September 30, 2017March 31, 2021 and 2016,2020, respectively. During the three months ended March 31, 2021, the Company recorded $94 related to estimated earnings under the fiscal year 2021 annual performance fee target. This amount is included in general and administrative expenses in the accompanying consolidated statements of operations.

 

The CompanyLifeway is also a party to a royalty agreement with the Chairperson of its board of directors under which the Company payswe pay the Chairperson a royalty based on the sale of certain Lifeway product,products, not to exceed $50 in any fiscal month. Royalties earned by the Chairperson are included in selling expenses in the accompanying consolidated statements of income and comprehensive incomeoperations and were $450$150 during the nine months ended September 30, 2017 and 2016, and $150 duringeach of the three months ended September 30, 2017March 31, 2021 and 2016.2020.

 

Note 14 – Subsequent EventCOVID-19

 

On September 24, 2015,The ultimate impact that the Company's BoardCOVID-19 pandemic or any future pandemic or disease outbreak will have on our business and our consolidated results of Directors authorizedoperations is uncertain.

To date we have seen increased customer and consumer demand for our products as consumers initially began pantry loading and have increased their at-home consumption as a stock repurchase program (the “2015 stock repurchase program”) under whichresult of social distancing and stay-at-home and work-from-home mandates and recommendations. However, this increased customer and consumer demand may decrease in the Companycoming months if and when the need for social distancing and stay-at-home and work-from-home mandates and recommendations decrease, and we are unable to predict the nature and timing of when that impact may from timeoccur, if at all.

Although to time, repurchase shares of its common stockdate we have not experienced supply chain constraints, and we have continued to be able to fully satisfy customer and consumer demand for an aggregate purchase price not to exceedour products, the lesser of $3,500 or 250 shares. On November 1, 2017, the Company’s Board of Directors amended the Company’s 2015 stock repurchase program (the “2017 amendment”), by increasing the authorization to the lesser of $5,185 or 625 shares, exclusivecontinued unprecedented demand for food and other consumer packaged goods products as a result of the shares previously authorized underCOVID-19 pandemic or any future pandemic may limit the 2015 stock repurchase program. Underavailability of, or increase the amended authorization, share repurchasescost of, ingredients, packaging and other raw materials necessary to produce our products, and our operations may be executed through various means,negatively impacted. Additionally, pandemics or disease outbreaks could result in a widespread health crisis that could adversely affect economies and financial markets, consumer spending and confidence levels resulting in an economic downturn that could affect customer and consumer demand for our products.

Our efforts to manage and mitigate these factors may be unsuccessful, and the effectiveness of these efforts depends on factors beyond our control, including the duration and severity of any pandemic or disease outbreak, as well as third party actions taken to contain its spread and mitigate public health effects.

The ultimate impact of the COVID-19 pandemic on our business will depend on many factors, including, among others, the duration of social distancing and stay-at-home and work-from-home mandates and recommendations and whether additional waves of COVID-19 or different variants of COVID-19 will affect the United States and other markets, our ability and the ability of our suppliers to continue to operate our and their manufacturing facilities and maintain the supply chain without limitationmaterial disruption and procure ingredients, packaging and other raw materials when needed despite unprecedented demand in the open market or in privately negotiated transactions, in accordance with all applicable securities lawsfood industry, and regulations, including without limitation Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The extent to which macroeconomic conditions resulting from the Company repurchases its sharespandemic and the timingpace of such repurchases will depend upon a varietythe subsequent recovery may impact consumer eating and shopping habits. We cannot predict the duration or scope of factors, including market conditions, regulatory requirements and other corporate considerations. The repurchase program does not obligate the Company to purchase any shares, anddisruption. Therefore, the program mayfinancial impact cannot be terminated, suspended, increased, or decreased by the Company’s Board of Directors in its discretionreasonably estimated at anythis time.

 

 

 1416 

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) in this Form 10-Q is provided as a supplement to, and should be read in conjunction with, our audited consolidated financial statements, the accompanying notes, and the MD&A included in our Annual Report on Form 10-K for the fiscal year ended December 31, 20162019 (the “Form 10-K”). Unless otherwise specified, any description of “our”, “we”, and “us” in this MD&A refer to Lifeway Foods, Inc. and our subsidiaries.

 

Cautionary Statement Regarding Forward-Looking Statements

 

In addition to historical information, this quarterly report contains “forward-looking” statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of words such as "anticipate," "intend," "plan,“anticipate,” “from time to time,” “intend,” “plan,” “ongoing,” “realize,” “should,” “may,” “could," "believe," "estimate,"future," "depend," "expect," "future,"will," "result," "can," "remain," "assurance," "subject to," "require," "limit," "impose," "guarantee," "restrict," "continue," "become," "predict," "likely," "may,"opportunities," "should,"effect," "will""change," "predict," and "estimate,” and similar terms or terminology, or the negative of such terms or other comparable terminology. Examples of forward-looking statements include, among others, statements we make regardingregarding:

 

 ·Expectations of the effect on our financial condition of claims, litigation, environmental costs, contingent liabilities and governmental and regulatory investigations and proceedings;
 ·Strategy for acquisitions, customer retention, growth, product development, market position, financial results and reserves; Estimates of the amounts of sales allowances and discounts to our customers and consumers;
 ·Our belief that we will maintain compliance with our loan agreements and have sufficient liquidity to fund our business operations;operations.

 

Forward-lookingForward looking statements are neither historical facts nor assurancesbased on management’s beliefs, assumptions, estimates and observations of future performance. Instead, theyevents based on information available to our management at the time the statements are based only on our current beliefs, expectationsmade and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-lookinginclude any statements that do not relate to theany historical or current fact. These statements are not guarantees of future performance and they are subject to inherentinvolve certain risks, uncertainties risks and changes in circumstancesassumptions that are difficult to predictpredict. Actual outcomes and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could causewhat is expressed, implied or forecast by our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others,due in part to the following:risks, uncertainties, and assumptions that include:

 

 ·The impactactions of investigativeour competitors and legal proceedings;customers, including those related to price competition;
 ·Developments and changes in laws and regulations, including regulationThe decisions of the dairycustomers or food industries through legislative action and revised rules and standards applied by the Food & Drug Administration (FDA);consumers;
 ·Economic and financial conditions, including volatility in interest and exchange rates, commodity and equity prices, and the value ofOur ability to successfully implement our assets;business strategy;
 ·Changes in the pricepricing of milk and other key materials and disruptions in supply chains for these materials;commodities
 ·Strategic actions, including acquisitions and dispositions and our success in launching new products;The effects of government regulation;
 ·The impact of the COVID-19 outbreak on our competitive position if we do not maintain compliance withbusiness, suppliers, consumers, customers, and employees;
·Disruptions to our loan agreements and/supply chain, or sufficient liquidityour manufacturing and distribution capabilities, including those due to fund our business operations;cybersecurity threats and the COVD-19 outbreak; and
 ·Such other factors as discussed throughout Part I, Item 1 “Business”; Part I, Item 1A “Risk Factors”; and Part II, Item 7 “Management's Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 20162020 and that are described from time to time in our filings with the SEC.

  

These factors are not necessarily all of the important factors that could cause actual results to differ materially from those expressed in any of our forward-looking statements. Other unknown or unpredictable factors could also have material adverse effects on future results. We intend these forward-looking statements to speak only at the date made. Except as otherwise required to be disclosed in periodic reports required to be filed by public companies with the SEC pursuant to the SEC's rules, we have no duty to update these statements, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Recent Developments

COVID-19 Pandemic Impact

In December 2019, a novel coronavirus disease ("COVID-19") was first reported and subsequently characterized by the World Health Organization ("WHO") as a pandemic in March 2020. In an effort to reduce the global transmission of COVID-19, various policies and initiatives have been implemented by governments around the world, including orders to close businesses not deemed "essential", shelter-in-place orders enacted by state and local governments, and the practice of social distancing measures when engaging in essential activities. Lifeway has seen increased orders from retail customers in response to increased consumer demand for food at home in response to government mandated social distancing and shelter in place orders in the United States and the immune boosting quality of our products.

 

 

15

Three Months Ended September 30, 2017 Compared to Three Months Ended September 30, 2016

Results of Operations

  September 30,  Change 
  2017  2016  $  % 
             
Net sales $28,786  $29,990  $(1,204)  (4.0%)
                 
Cost of goods sold $20,331  $21,478  $1,147     
Depreciation expense  618   533   (85)    
Total cost of goods sold $20,949  $22,011  $1,062   4.8% 
                 
Gross profit $7,837  $7,979  $(142)  (1.8%)
Gross Profit % to net sales  27.2%   26.6%         
                 
Selling expenses $4,010  $4,306  $296   6.9% 
Selling expenses % to net sales  13.9%   14.4%         
                 
General & administrative expenses $3,145  $3,308  $163   4.9% 
General & administrative % to net sales  10.9%   11.0%         
                 
Amortization expense $168  $176  $8   4.5% 
                 
Total operating expenses $7,323  $7,790  $467   6.0% 
Total operating expense % to net sales  25.4%   26.0%         
Income from operations $514  $189  $325   172.0% 
Income from operations % to net sales  1.8%   0.6%         

Net Sales

Net sales decreased by $1,204 or 4.0% to $28,786. Volume / mix subtracted 7.0% from net sales; pricing added 0.8% to net sales and trade promotion and allowances added 2.2% to overall net sales. The 7.0% volume / mix decline was driven by lower volumes of our branded drinkable kefir partially offset by the impact of new item introductions (primarily cupped kefir) and an increase in sales of private label products.

Gross Profit

Gross profit as a percent of net sales increased to 27.2% during the three-month period ended September 30, 2017 from 26.6% during the same three-month period in 2016. The higher gross profit percent reflects lower trade promotion and lower delivery costs partially offset by the unfavorable impact of labor and overhead costs on lower net sales in the 2017 period.

Selling Expenses

Selling expenses decreased by $296 or 6.9% to $4,010 during the three-month period ended September 30, 2017 from $4,306 during the same period in 2016. The lower selling expenses reflects lower advertising costs, partially offset by higher salaries. During the third quarter of 2017 we ran our “Probiotic Billionaire” advertising campaign focused on the functional benefits of Lifeway’s kefir. During the third quarter of 2016 we ran a broad-based advertising campaign that featured our brand ambassador and Olympic athlete Carly Lloyd. The production costs of the 2016 campaign were more costly than the 2017 campaign. The increase in salaries reflects a headcount increase in our salesforce. Selling expenses as a percentage of net sales were 13.9% for the three-month period ended September 30, 2017 compared to 14.4% for the same period in 2016.

General and administrative expenses

General and administrative expenses decreased $163 or 4.9% to $3,145 during the three-month period ended September 30, 2017 from $3,308 during the same period in 2016. The decrease is primarily a result of lower professional fees.

16

Income from operations and net income

The company reported income from operations of $514 during the three months ended September 30, 2017, compared to $189 during the same period in 2016. Provision for income taxes was $175 during the three months ended September 30, 2017, compared to a provision for income taxes of $81 during the same period in 2016. Our effective tax rate (ETR) for the three months ended September 30, 2017 was 41.9% compared to an ETR which exceeded 100.0% in the same period last year. The ETR for the three months ended September 30, 2016 reflects a change in the estimated U.S. manufacturing deduction and the relatively small amount of income before provision for income taxes.

Income taxes are discussed in Note 9 in the Notes to the Consolidated Financial Statements.

We reported net income of $243 or $0.02 per basic and diluted common share for the three-month period ended September 30, 2017 compared to a net loss of $64 or $0.00 per basic and diluted common share in the same period in 2016.

Comparison of the nine-month period ended September 30, 2017 to the nine-month period ended September 30, 2016

Results of Operations

  September 30,  Change 
  2017  2016  $  % 
             
Net sales $92,636  $93,691  $(1,055)  (1.1%)
                 
Cost of goods sold $65,262  $65,480  $218     
Depreciation expense  1,801   1,797   (4)    
Total cost of goods sold $67,063  $67,277  $214   0.3% 
                 
Gross profit $25,573  $26,414  $(842)  (3.2%)
Gross Profit % to net sales  27.6%   28.2%         
                 
Selling expenses $11,648  $10,733  $(915)  (8.5%)
Selling expenses % to net sales  12.6%   11.5%         
                 
General & administrative expenses $10,743  $10,300  $(443)  (4.3%)
General & administrative % to net sales  11.6%   11.0%         
                 
Amortization expense $504  $529  $25   4.7% 
                 
Total operating expenses $22,895  $21,562  $(1,333)  (6.2%)
Total operating expense % to net sales  24.7%   23.0%         
Income from operations $2,678  $4,852  $(2,174)  (44.8%)
Income from operations % to net sales  2.9%   5.2%         

Net Sales

Net sales decreased by $1,055 or 1.1% to $92,636.  Volume / mix subtracted 1.6% from net sales; pricing added 0.7% to net sales and trade promotion subtracted 0.2% from overall net sales. The 1.6% decline in volume / mix was driven by lower volumes of our branded drinkable kefir partially offset by the impact of new item introductions and an increase in sales of private label product.

Gross Profit

Gross profit as a percent of net sales decreased to 27.6% during the nine-month period ended September 30, 2017 from 28.2% during the same period in 2016. The lower gross profit percent was driven by higher milk costs and increased trade promotion partially offset by lower delivery costs.

 17 

 

 

Selling ExpensesLocal, state, and national governments continue to emphasize the importance of food supply during this pandemic and asked that food manufacturers and retailers remain open to meet the needs of our communities. The health and safety of our employees throughout this pandemic is paramount, and we have taken numerous steps to keep our employees safe including enhanced sanitation protocols, implementation of social distancing measures at our manufacturing operations, masks and personal protective equipment for employees across our facilities, preventative temperature screenings across all manufacturing locations, the rollout of new benefits that help support our employees and their families, and remote work arrangements for administrative support functions to comply with shelter-in-place orders. In addition, a cross-functional task force has been established to monitor and coordinate the Company's response to COVID-19.

 

Selling expenses increased by $915 or 8.5%During the first quarter of 2020, Management, anticipating the spread of COVID-19 and its effects, implemented a plan to $11,648 during the nine-month period ended September 30, 2017 from $10,733 during the same period in 2016.  The increased selling expenses reflects higher salaries partially offset by lower advertisingmitigate effects of COVID-19 on supply and marketing related costs. The higher salaries was driven by a headcount increase intransportation of materials used to make and package our salesforce. The lower advertisingproducts, staffing, and marketing related costs were driven by the lower production coststransportation of our 2017 advertising campaign. Selling expenses as a percentage of netproducts to customers. Management’s proactive planning allowed the Company to avoid disruption to its manufacturing facilities and production, transportation, and sales were 12.6% forand to meet the nine-month period ended September 30, 2017 compared to 11.5% forincreased demand without delay. The Company has full production capacity available at all locations at this time and does not anticipate manufacturing or staffing disruptions in the same period in 2016.near term.

  

General and administrative expenses

General and administrative expenses increased $443 or 4.3% to $10,743 during the nine-month period ended September 30, 2017 from $10,300 during the same period in 2016. The increase is primarily a resultResults of higher salaries partially offset by lower professional fees.  The increase in salaries reflects higher levels of executive compensation for senior management driven by incentive compensation and an increase in the headcount of the overall management team. 

Income from operations and net income

The company reported income from operations of $2,678 during the nine months ended September 30, 2017, compared to $4,852 during the same period in 2016. Provision for income taxes was $1,056, or a 42.9% effective tax rate (ETR) during the nine months ended September 30, 2017, compared to a provision for income taxes of $1,476 or a 33.0% effective tax rate, during the same period in 2016. During the nine months ended September 30, 2016 the Company recorded an income tax benefit of $265 as a result of the favorable settlement of uncertain tax positions, which reduced the ETR by 5.9%.

Income taxes are discussed in Note 9 in the Notes to the Consolidated Financial Statements.

We reported net income of $1,403 or $0.09 per basic and diluted common share for the nine-month period ended September 30, 2017 compared to $2,998 or $0.19 per basic and diluted common share in the same period in 2016.Operations

 

Liquidity and Capital ResourcesThree Months Ended March 31, 2021 Compared to Three Months Ended March 31, 2020

 

Sources and Uses of Cash

  March 31,  Change 
  2021  2020  $  % 
Net sales $29,376  $25,388  $3,988   15.7%
                 
Cost of goods sold $20,512  $18,624  $(1,888)    
Depreciation expense  815   767   (48)    
Total cost of goods sold $21,327  $19,391  $(1,936)  (10.0%)
                 
Gross profit $8,049  $5,997  $2,052   34.2%
Gross Profit % to net sales  27.4%  23.6%        
                 
Selling expenses $3,222  $2,575  $(647)  (25.1%)
Selling expenses % to net sales  11.0%  10.1%        
                 
General and administrative expenses $2,891  $3,145  $254   8.1%
General and administrative % to net sales  9.8%  12.4%        
                 
Amortization expense $  $39  $39   100.0%
                 
Total operating expenses $6,113  $5,759  $(354)  (6.1%)
Total operating expense % to net sales  20.8%  22.7%        
                 
Income from operations $1,936  $238  $1,698   713.4%
Income from operations % to net sales  6.6%  0.9%        
                 
Total other income (expense) $(37) $(37) $   0.0%
Total other income (expense) % to net sales  (0.1%)  (0.1%)        
                 
Income before provision for income taxes $1,899  $201  $1,698   844.8%
Income before provision for income taxes % to net sales  6.5%  0.8%        
                 
Provision for income taxes $593  $55  $(538)  (978.2%)
Provision for income taxes % to net sales  2.0%  0.2%        
                 
Net income $1,306  $146  $1,160   794.5%
Net income % to net sales  4.5%  0.6%        

 

We anticipate being able to fund the Company's foreseeable liquidity requirements internally. We also have unused credit lines as discussed in Note 7 to the consolidated financial statements and we anticipate future compliance with our loan agreements. We continue to explore potential acquisition opportunities in our industry in order to boost sales while leveraging our distribution system to consolidate and lower costs.

Net cash provided by operating activities was $4,189 during the nine months ended September 30, 2017 compared to net cash provided by operating activities of $4,513 in the same period in 2016. The decline in cash provided by operating activities reflects relatively lower net income partially offset by an increase in non-cash charges primarily related to stock-based compensation and the favorable impact of relatively lower working capital during 2017. The favorable impact of working capital on operating cash flow was driven by the favorable timing of payments to suppliers and service providers and lower inventory levels in the 2017 period.

Net cash used in investing activities was $3,920 during the nine months ended September 30, 2017 compared to net cash provided by investing activities of $373 in the same period in 2016. The lower level of net cash used in investing activities in the 2016 period reflects liquidity provided from our investments in part to fund share repurchase activity. Capital spending was $3,932 during the nine months ended September 30, 2017 compared to $2,481 in the same period in 2016 reflecting our continuing investments in new production equipment.

Net cash used in financing activities was $1,817 during the nine months ended September 30, 2017 compared to net cash used in financing activities of $1,368 in the same period in 2016. We repurchased approximately 117 and 69 shares of common stock at a cost of $1,187 and $738 in the nine-month periods ended September 30, 2017 and September 30, 2016 respectively.

 

 

 18 

 

  

On September 24, 2015,Net Sales

Net sales finished at $29,376 for the Company's Boardthree-month period ended March 31, 2021, an increase of Directors authorized$3,988 or 15.7% versus prior year. The net sales increase was primarily driven by higher volumes of our branded drinkable kefir. Approximately 30% of the increase results from the Farmers to Families Food Box program with the United States Department of Agriculture (“USDA”) which began during the middle of the first quarter of 2021. The program is scheduled to end in May 2021.

Gross Profit

Gross profit as a stock repurchase programpercentage of net sales was 27.4% during the three-month period ended March 31, 2021. Gross profit percentage was 23.6% in the prior year. The increase versus the prior year was primarily due to the favorable impact of operating leverage that arises from higher net sales relative to fixed costs, and to a lesser extent favorable milk pricing. Additionally, depreciation expense increased reflecting our continued investment in manufacturing improvements.

Selling Expenses

Selling expenses increased by $647 or 25.1% to $3,222 during the three-month period ended March 31, 2021 from $2,575 during the same period in 2020. The increase versus prior year primarily reflects an increase in advertising expense related to a television and digital advertising campaigns in the first quarter of 2021, partially offset by lower compensation expense. Selling expenses as a percentage of net sales were 11.0% during the three-month period ended March 31, 2021 compared to 10.1% for the same period in 2020.

General and Administrative Expenses

General and administrative expenses decreased 254 or 8.1% to $2,891 during the three-month period ended March 31, 2021 from $3,145 during the same period in 2020. The decrease is primarily a result of lower compensation expense due to organizational changes made in 2020 and lower professional fees.

Provision for Income Taxes

The provision for income taxes includes federal, state and local income taxes. The provision for income taxes was $593 and $55 during the three months ended March 31, 2021 and 2020, respectively.

Our effective income tax rate for the three months ended March 31, 2021 was 31.2% compared to 27.5% in the same period last year. During the first quarter of 2020, the company’s effective tax rate was reduced due to provisions of the CARES Act. That law provided for the carryback of certain net operating losses to years in which the tax rates were significantly higher. The tax benefit was recorded as a discrete item in the first quarter of 2020. The statutory Federal and state tax rates remained consistent from 2020 to 2021. The Company has a number of items that are nondeductible or are discrete adjustments to tax expense. Although similar items were reflected in 2021, the percentage effect is lower due to the increase in pre-tax income in 2021 compared to 2020.

Our effective tax rate may change from period to period based on recurring and non-recurring factors including the relative mix of pre-tax earnings (or losses), the underlying income tax rates applicable to various state and local taxing jurisdictions, enacted tax legislation, the impact of non-deductible items, changes in valuation allowances, and the expiration of the statute of limitations in relation to unrecognized tax benefits. We record discrete income tax items such as enacted tax rate changes and completed tax audits in the period in which they occur.

19

Section 162(m) of the Internal Revenue Code (the “2015 stock repurchase program”“Code”) limits the deductibility of compensation paid to certain of our executives. Under the Tax Cuts and Jobs Act (the “Act”) amendments to Section 162(m), no tax deduction in taxable years beginning after December 31, 2017 is allowed for compensation paid to any covered employee to the extent that the total compensation for that covered employee exceeds $1,000,000 in any taxable year. Although the Act eliminated the prior tax deduction under Section 162(m) for performance-based executive compensation, it included a transition rule under which the changes to Section 162(m) will not apply to awards made to our covered employees who had the right to participate in our 2015 Omnibus Incentive Plan pursuant to written binding contracts in effect as of November 2, 2017, as long as those contracts have not subsequently been modified in any material respect. Accordingly, subject to further guidance from the Treasury Department and the Internal Revenue Service (“IRS”), the performance-based compensation paid to our executives under our Omnibus Plan remained eligible for the Section 162(m) exemption through 2019. Beginning in 2020, compensation exceeding the threshold for covered employees is non-deductible for income tax purposes.

Income taxes are discussed in Note 10 in the Notes to the Consolidated Financial Statements.

Net Income

We reported net income of $1,306 or $0.08 per basic and diluted common share for the three months ended March 31, 2021 compared to net income of $146 or $0.01 per basic and diluted common share in the same period in 2020.

Liquidity and Capital Resources

The ultimate impact that the COVID-19 pandemic or any future pandemic or disease outbreak will have on our business and our consolidated results of operations is uncertain.

To date we have seen increased customer and consumer demand for our products as consumers initially began pantry loading and have increased their at-home consumption as a result of social distancing and stay-at-home and work-from-home mandates and recommendations. However, this increased customer and consumer demand may decrease in the coming months if and when the need for social distancing and stay-at-home and work-from-home mandates and recommendations decrease, and we are unable to predict the nature and timing of when that impact may occur, if at all.

Although to date we have not experienced supply chain constraints, and we have continued to be able to fully satisfy customer and consumer demand for our products, the continued unprecedented demand for food and other consumer packaged goods products as a result of the COVID-19 pandemic or any future pandemic may limit the availability of, or increase the cost of, ingredients, packaging and other raw materials necessary to produce our products, and our operations may be negatively impacted. Additionally, pandemics or disease outbreaks could result in a widespread health crisis that could adversely affect economies and financial markets, consumer spending and confidence levels resulting in an economic downturn that could affect customer and consumer demand for our products.

Our efforts to manage and mitigate these factors may be unsuccessful, and the effectiveness of these efforts depends on factors beyond our control, including the duration and severity of any pandemic or disease outbreak, as well as third party actions taken to contain its spread and mitigate public health effects.

The ultimate impact of the COVID-19 pandemic on our business will depend on many factors, including, among others, the duration of social distancing and stay-at-home and work-from-home mandates and recommendations and whether additional waves of COVID-19 or different variants of COVID-19 will affect the United States and other markets, our ability and the ability of our suppliers to continue to operate our and their manufacturing facilities and maintain the supply chain without material disruption and procure ingredients, packaging and other raw materials when needed despite unprecedented demand in the food industry, and the extent to which macroeconomic conditions resulting from the pandemic and the pace of the subsequent recovery may impact consumer eating and shopping habits. We cannot predict the duration or scope of the disruption. Therefore, the financial impact cannot be reasonably estimated at this time.

20

To date, our manufacturing facilities have not been significantly impacted. We have full production capacity available at all locations at this time. On March 16, 2020, the food industry, including grocery stores and their suppliers, and transportation were classified by the U.S. federal government as critical infrastructure industry. As a result, our employees and facilities, as well as the retailers and distributors that sell our products, will be able to remain in operation. During the first quarter of 2020, Management, anticipating the spread of Covid-19 and its effects, implemented a plan to mitigate effects of Covid-19 on supply and transportation of materials used to make and package our products, staffing, and transportation of our products to customers. While the situation is fluid, we have evaluated all manufacturing locations and do not anticipate any staffing shortages or interruption of our production, transportation and sale of products in the near term.

Cash Flow

At this time, the COVID-19 pandemic has not materially impacted on our operations. We expect to meet our foreseeable liquidity and capital resource requirements through anticipated cash flows from operations; our revolving credit facility; and cash and cash equivalents to ensure the continuation of the Company may, from timeas a going concern. The success of our business and financing strategies will continue to time, repurchase sharesprovide us with the financial flexibility to take advantage of its common stock for an aggregate purchase price notvarious opportunities as they arise. Given the dynamic nature of COVID-19, we will continue to exceedassess our liquidity needs while continuing to manage our discretionary spending and investment strategies.

Sources and Uses of Cash

Lifeway had a net increase in cash and cash equivalents of $692 during the lesserthree-month period ended March 31, 2021 compared to a net decrease in cash and cash equivalents of $3,500 or 250 shares. $1,858 in the same period in 2020. The drivers of the year over year change are as follows:

Net cash provided in operating activities was $1,210 during the three-month period ended March 31, 2021 compared to net cash used by operating activities of $1,055 in the same period in 2020. The increase in cash provided by operating activities is primarily due to the increase in cash generated through higher revenues and reduced expenses in 2021, and the change in working capital. Working capital consumption was higher in 2020 due to increased revenue in March 2020 as consumers anticipated the shelter in place directives that ultimately occurred as a result of the COVID-19 pandemic.

Net cash used in investing activities was $518 during the three-month period ended March 31, 2021 compared to net cash used in investing activities of $398 in the same period in 2020. The increase in net cash used in investing activities in 2021 reflects higher capital spending. Capital spending was $518 during the three-month period ended March 31, 2021 compared to $403 in 2020. Our capital spending is focused in three core areas: growth, cost reduction, and facility improvements. Growth capital spending supports new product innovation and enhancements. Cost reduction and facility improvements support manufacturing efficiency, safety and productivity.

Net cash used in financing activities was $0 during the three-month period ended March 31, 2021 compared to net cash used in financing activities of $405 in the same period in 2020.

On November 1, 2017, Lifeway’s Board approved an increase in the Company’s Board of Directors amended the Company’saggregate amount under our previously announced 2015 stock repurchase program (the “2017 amendment”Repurchase Plan Amendment”), by increasing the authorizationadding to the lesser of $5,185 or 625 shares,(i.e., exclusive of the shares previously authorized under the 2015 stock repurchase program. Underprogram) the authorization the lesser of $5,185 or 625 shares. We repurchased approximately 178 shares of common stock at a cost of $405 during the three-month period ended March 31, 2020 under the 2017 Repurchase Plan Amendment. As of March 31, 2021, there were no shares of common stock that remained available to be purchased under the 2017 Repurchase Plan Amendment. We intend to hold repurchased shares in treasury for general corporate purposes, including issuances under our 2015 Omnibus Incentive Plan. Treasury shares are accounted for using the cost method.

Debt Obligations

On September 30, 2020, Lifeway entered into the Third Modification to the Amended and Restated Loan and Security Agreement, as amended, authorization, share repurchases(the “Third Modification”) with its existing lender. The Third Modification amends the Amended and Restated Loan and Security Agreement, as amended, by removing the monthly borrowing base reporting requirement effective September 30, 2020, including a covenant to maintain a quarterly minimum working capital financial covenant, as defined, of no less than $11.25 million each of the fiscal quarters commencing the fiscal quarter ended December 31, 2020 through the expiration date, and eliminating the tier interest pricing structure. The Amended and Restated Loan and Security Agreement continues to provide Lifeway with a revolving line of credit up to a maximum of $5 million (the “Revolving Loan”) and provides the Borrowers with an incremental facility not to exceed $5 million (the “Incremental Facility” and together with the Revolving Loan, the “Loans”). The Termination Date of the Revolving Loan was extended to June 30, 2025, unless earlier terminated.

21

Except as described above, amended, the Modified Revolving Credit Facility remains substantively unchanged and in full force and effect, including customary representations, warranties, and covenants on the part of Lifeway, including financial covenants requiring us to maintain a fixed charge coverage ratio of no less than 1.25 to 1.00 each of the fiscal quarters ending through the expiration date. The Modified Revolving Credit Facility continues to provide for events of default, including failure to repay principal and interest when due and failure to perform or violation of the provisions or covenants of the agreement, as a result of which amounts due under the Modified Revolving Credit Facility may be executed through various means, including without limitationaccelerated.

As of March 31, 2021, we had $2,774 net of $3 of unamortized deferred financing costs, outstanding under the Revolving Credit Facility. We had $2,223 available for future borrowings as of March 31, 2021.

As amended, all outstanding amounts under the Loans bear interest, at Lifeway’s election, at either the lender Base Rate (the Prime Rate minus 1.00%) or the LIBOR plus 1.95%, payable monthly in arrears. Lifeway is also required to pay a quarterly unused line fee of 0.20% and, in conjunction with the open market orissuance of any letters of credit, a letter of credit fee of 0.20%. Lifeway’s interest rate on debt outstanding under our Revolving Credit Facility as of March 31, 2021 was 2.15%.

We are in privately negotiated transactions, in accordancecompliance with all applicable securities lawsfinancial debt covenants as of March 31, 2021. See Note 7 to our Consolidated Financial Statements for additional information regarding our indebtedness and regulations, including without limitation Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon a variety of factors, including market conditions, regulatory requirements and other corporate considerations. The repurchase program does not obligate the Company to purchase any shares, and the program may be terminated, suspended, increased, or decreased by the Company’s Board of Directors in its discretion at any time.

The Company had a net decrease in cash and cash equivalents of $1,548 during the nine-month period ended September 30, 2017 compared to a net increase in cash and cash equivalents of $3,518 in the same period in 2016.

At September 30, 2017, the Company had $3,292 of current maturities of notes payable. We intend to fund these maturities with available cash balances and / or new financing facilities. The Company also has a $5 million revolving credit facility. This facility expires in July 2018, remained unused at September 30, 2017 and is available for other general corporate purposes. The company is in compliance with the covenants contained in its loanrelated agreements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

For information regarding our exposure to certain market risk, see Item 7A, Quantitative and Qualitative Disclosures About Market Risk, in the Form 10-K. There have been no significant changes in our market risk exposures from the 2016 year-end.Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

(a)Evaluation of Disclosure Controls and Procedures

Evaluation of Disclosure Controls and Procedures

 

Our evaluation of the effectiveness of ourWe have established disclosure controls and procedures as(as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act was performed under the supervision and with the participation of our senior management, including our Chief Executive Officer and Chief Financial Officer. The purpose of disclosure controls and procedures is1934 (the “Exchange Act”)) designed to ensure that information required to be disclosed in theour reports we filefiled or submitsubmitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’sSecurities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

As previously disclosed under “Item 9A—Controlsdisclosure. Management, with the participation of the Chief Executive Officer and Procedures” in our Annual Report on Form 10-K forChief Financial Officer, evaluated the fiscal year ended December 31, 2016, we concluded that our internal control over financial reporting was not effective based oneffectiveness of the material weakness identified. Based on the material weakness, which we view as an integral part of ourCompany’s disclosure controls and procedures as of March 31, 2021. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the quarter ended September 30, 2017, our disclosure controls and procedures were not effective. Nevertheless, based on a numbereffective as of factors, including the performance of additional procedures by management designed to ensure the reliability of our financial reporting, we believe that the consolidated financial statements in this Quarterly Report on Form 10-Q fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with GAAP.

(b)Changes in Internal Control over Financial Reporting

Our remediation efforts were ongoing during the three months ended September 30, 2017. Remediation generally requires making changes to how controls are designed and implemented and then adhering to those changes for a sufficient period of time such that the effectiveness of those changes is demonstrated with an appropriate amount of consistency. We have taken certain remediation steps to address the material weaknesses referenced above and to improve our control over financial reporting. If not remediated these deficiencies could result in material misstatements to our consolidated financial statements.

In addition to the actions previously disclosed under “Item 9A—Controls and Procedures” in our Annual Report on Form 10-K for the fiscal year ended DecemberMarch 31, 2016, our remediation initiatives summarized below, are intended to further address our specific material weaknesses and to continue to enhance our internal control over financial reporting.2021.

19

Management’s Remediation Initiatives

During the nine months ended September 30, 2017 we took the following actions to improve our internal controls over financial reporting:

·We have continued to emphasize the importance of, and monitor the sustained compliance with, the execution of our internal controls over financial reporting.

·We have continued to work with our third-party service provider to ensure that our accounting and reporting for income taxes are timely and accurate.

·We have increased the number of employees authorized to review and sign checks from two to three to improve timeliness and add redundancy to the internal controls over the cash disbursements process. We have also updated our invoice approval policy to clarify authority levels of company personnel submitting invoices to our accounts payable department for payment.

·We have installed software and implemented new procedures designed to improve user provisioning and user access rights to our ERP system.

·We have hired a senior staff accountant to increase the size of our controller’s department. We began on-boarding the senior staff accountant in connection with our third quarter reporting period.

 

There were no other material changes in our internal control over financial reporting that occurred(as defined in Rule 13a-15(f) of the Exchange Act) during the nine monthsquarter ended September 30, 2017March 31, 2021 that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

 

 2022 

 

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

WeFrom time to time we are a party to various lawsuits, proceedings, and otherengaged in litigation matters arising outin the ordinary course of business. While the conductresults of our business. Currently, itlitigation and claims cannot be predicted with certainty, Lifeway believes that no such matter is management’s opinion that the ultimate resolution of these matters will notreasonably likely to have a material adverse effect on our business, financial condition,position or results of operation, or cash flows.operations.

 

ITEM 1A. RISK FACTORS.

 

There have been no material changes with respect to the Risk Factorsrisk factors disclosed in Part I, Item 1A of our Annual Report on2020 Form 10-K for the fiscal year ended December 31, 2016.10-K.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

Issuer Purchases of Equity Securities

None.

  

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURE.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

None.

23

 

ITEM 6. EXHIBITS.

 

10.1No.Thirteenth Modification to Loan and Security Agreement effective July 6, 2017, by and among The PrivateBank and Trust Company, Lifeway Foods, Inc., Fresh Made, Inc., Helios Nutrition Limited, The Lifeway Kefir Shop, LLC and Lifeway Wisconsin, Inc.DescriptionFormPeriod EndingExhibitFiling Date
10.2Fourteenth Modification to Loan and Security Agreement effective July 20, 2017, by and among The PrivateBank and Trust Company, Lifeway Foods, Inc., Fresh Made, Inc., Helios Nutrition Limited, The Lifeway Kefir Shop, LLC and Lifeway Wisconsin, Inc.
10.3Fifteenth Modification to Loan and Security Agreement effective November 1, 2017, by and among CIBC Bank USA f/k/a The PrivateBank and Trust Company, Lifeway Foods, Inc., Fresh Made, Inc., Helios Nutrition Limited, The Lifeway Kefir Shop, LLC and Lifeway Wisconsin, Inc.
31.1Officer’s Certificate Pursuant to 15 U.S.C. 7241, as Adopted Pursuant to Section 302Rule 13a-14(a)/15d-14(a) Certification of the Sarbanes-Oxley Act of 2002.Julie SmolyanskyFiled Herewith
31.2Officer’s Certificate Pursuant to 15 U.S.C. 7241, as Adopted Pursuant to Section 302Rule 13a-14(a)/15d-14(a) Certification of the Sarbanes-Oxley Act of 2002.Eric HansonFiled Herewith
32.1Section 1350 Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.Julie Smolyansky*Furnished Herewith
32.2Section 1350 Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.Eric Hanson*Furnished Herewith
99.1*
99.1Press release dated November 14, 2017May 17, 2021 reporting the Company'sLifeway’s financial results for the three and nine months ended September 30, 2017.March 31, 2021.*Furnished Herewith
101Interactive Data Files.FilesFiled Herewith

 

*       This exhibit isThe exhibits deemed furnished with this Form 10-Q and willare not deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall they be deemed "filed.”incorporated by reference into any filing under the Securities Act or the Exchange Act., whether made before or after the date of the filing of this Form 10-Q and irrespective of any general incorporation language contained in such filing.

 

 

 2124 

 

SIGNATURES

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 LIFEWAY FOODS, INC.
 
Date: May 17, 2021By:  /s/ Julie Smolyansky
Julie Smolyansky
Chief Executive Officer, President, and Director
(Principal Executive Officer)
   
   
   
Date: November 14, 2017May 17, 2021By:  /s/ Julie SmolyanskyEric Hanson
  Julie Smolyansky
Chief Executive Officer, President, and Director
(Principal Executive Officer)
Date: November 14, 2017By:  /s/ John P. Waldron
John P. WaldronEric Hanson
  Chief Financial & Accounting Officer
  (Principal Financial and Accounting Officer)

22

INDEX OF EXHIBITS

10.1Thirteenth Modification to Loan and Security Agreement effective July 6, 2017, by and among The PrivateBank and Trust Company, Lifeway Foods, Inc., Fresh Made, Inc., Helios Nutrition Limited, The Lifeway Kefir Shop, LLC and Lifeway Wisconsin, Inc.
10.2Fourteenth Modification to Loan and Security Agreement effective July 20, 2017, by and among The PrivateBank and Trust Company, Lifeway Foods, Inc., Fresh Made, Inc., Helios Nutrition Limited, The Lifeway Kefir Shop, LLC and Lifeway Wisconsin, Inc.
10.3Fifteenth Modification to Loan and Security Agreement effective November 1, 2017, by and among CIBC Bank USA f/k/a The PrivateBank and Trust Company, Lifeway Foods, Inc., Fresh Made, Inc., Helios Nutrition Limited, The Lifeway Kefir Shop, LLC and Lifeway Wisconsin, Inc.
31.1Officer’s Certificate Pursuant to 15 U.S.C. 7241, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2Officer’s Certificate Pursuant to 15 U.S.C. 7241, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.1*Press release dated November 14, 2017 reporting the Company's financial results for the three and nine months ended September 30, 2017.
101Interactive Data Files.

* This exhibit is furnished and will not be deemed "filed.”

 

 

 

 

 2325